|
|
News for Healthier Living
Dana-Farber Research Supports FDA Approval of New Therapy for "Double-Positive" Metastatic Breast Cancer
The U.S. Food and Drug Administration (FDA) has approved a new therapy regimen for patients with "double-positive" metastatic breast cancer based on results of the phase 3 PATINA study led by Otto Metzger, MD, Associate Medical Director of International Strategic Initiatives at Dana-Farber Cancer Institute. The PATINA trial demonstrated that the addition of the CDK 4/6 inhibitor palbociclib to standard therapy in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer resulted in a more than 15-month improvement in progression-free survival. The findings were reported in the New England Journal of Medicine and also presented at the San Antonio Breast Cancer Symposium in December 2024.
July 6, 2026
July 10 2026 - Rutgers-Led Center Spots Emerging Tobacco Threats Years Faster Than Conventional Surveillance
- Landmark Clinical Trial Results in First FDA-Approved Treatment for Rare Form of Obesity Caused by Brain Injury
- CVD and Collaborators Launch Study to Better Understand Immune Responses to Lassa Fever
- Research Tip Sheet: Cedars-Sinai Heart, Aging and Cancer Advances
- Studying Viral Proteins on a Whole New Scale
- Loss of Radiation Therapy Clinics Could Widen Cancer Care Gaps Across the United States
- Are you a journalist who covers science, health, or environmental issues?
- New Soft Wearable Device Could Support At-Home Sleep Monitoring
- New Research Seeks to Help Transplanted Cells Thrive in Type 1 Diabetes Treatment
- Katie Couric's Memory Loss Scare Puts Rare Brain Condition In Spotlight
- The Myth of the 'Lizard Brain' and the Real Trade-Off Inside Your Mind
- Mild COVID Can Lead To Long-Term Hidden Eye Problems
- Seniors Know How Sharp They Are At Any Given Time, Study Finds
- Smartphone App Uses Voice To Predict Asthma, COPD Flare-Ups
- LGBTQ+ People Less Likely To Be Screened For Some Common Cancers
- AI Can Detect Previously Invisible MS Scars In The Brain
- Patients Face A Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- JMIR Report: Machine Learning Accelerates Radiopharmaceutical Drug Discovery, Optimizes Personalized Dosimetry
- Among Young Adults, Alcohol-Induced Blackout Are Linked to More Harmful Consequences, With Stronger Associations in Certain Social and Drinking Contexts
- Study Reveals Major Shifts in Alcohol-Related Deaths
- Alcohol Intoxication, Stress in Adolescence Linked with Long-Term Impairments
- Young Adults' Attention to Alcohol Cues in their Environments is Highly Variable and Linked to Their Craving and Drinking, Potentially Informing Interventions
- Insurance Denials for Brand-Name Prescription Drugs Rose Sharply From 2018 to 2024
- Science Communications Research to Practice Webinar: Knowing Your Audience
- Turning Off Cancer-Promoting Signals, Turning On Attack Signals... Anticancer "Nanoswitch" Technology Developed
July 9 2026July 8 2026July 7 2026July 6 2026July 3 2026July 2 2026July 1 2026 - Study Finds Little to No Cortical Lewy Pathology in Living Parkinson's Disease Patients Undergoing Deep Brain Stimulation
- Program Dramatically Improves Safety of Surgery for Children
- Common Brain Cancer Mutation Changes DNA Shape to Drive Progression, Exposing Therapeutic Target
- Mayo Clinic Study Identifies New Brain Targets for Individualized Epilepsy Treatment
- ADLM Publishes First Comprehensive U.S. Guidance to Help Laboratory Medicine Professionals Meet the Needs of Gender Diverse Patients
- Study: New Biological Clues Behind Coffee's Benefit to Liver Health
- FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel
- Powering an Automated Pipeline for Drug Discovery
- SNAP Changes are Reshaping America's Food Safety Net, Threatening Food Access for Millions
- Exertion Tests Offer Insight Into Recovery From Youth Concussions
- Move to Quit: Exercise Boosts Smoking Quit Rates
- Can A Popular Muscle Supplement Help Treat Depression?
- Heat Dome Coming: Tips To Stay Safe During Extreme Temps
- Diets That Lower Inflammation Might Cut Dementia Risk, Study Indicates
- Melatonin Shows Promise As Safe, Cheap Painkiller, Review Concludes
- Vitamins Might Be Key To Asthma Control In Children, Adults
- Would Hunters Take A Lyme Disease Vaccine? We Asked
- Neurobiologists Improve Symptoms of Huntington's Disease with Targeted Brain Stimulation in Mice
- McMaster-Developed Immunotherapy Strategy Targets Aggressive Brain Tumours and Their Fuel
- UC San Diego Researchers Uncover Precision Medicine Strategy for Rare Inherited Muscle Disorders
- FAMU-FSU College of Engineering Researchers Improve Analysis of Molecules Linked to Alzheimer's Disease
- Should Lowest-Risk Prostate 'Cancer' Still Be Called Cancer? Study Suggests Changing the Name Could Save Lives
- Whether Children Receive Opioids After Surgery Varies by Hospital and Procedure Type
- JMIR News: AI Innovations, Digital Health Transformations, and New Medicare Models
- Tip Sheet: New Therapy Shows Promise for Pancreatic Cancer, Experts Redefine Survivorship -- and New Strategies for Preventing Skin Cancer
- Thawing Ground, Future Questions: Decoding Arctic Climate in a Pennsylvania Lab
June 30 2026June 29 2026
|
|
|
|
|